Ab&B Bio-Tech has joined the stacked roster of drug developers queuing up to go public in Hong Kong, filing the paperwork for ...

A 13-year-old girl in Canada became so sick with H5N1, or bird flu, in late 2024 that she had to be put on a ventilator.

While drugmakers are hard at work on the shots, they’re not yet ready to blunt the impact of a potential pandemic.

and Pfizer (PFE)/GSK (GSK)/CureVac (CVAC) for H5N1 avian flu. The investment firm noted that Moderna (MRNA) and Pfizer (PFE), along with Pfizer (PFE) partner BioNTech (BNTX), were being sued for ...

Moderna, Pfizer, and a partnership between GSK and CureVac are reportedly working ... and Prevention reported the first death from bird flu on Monday, announcing an elderly patient with underlying ...

Plus: Moderna’s bird flu vaccine, Obamacare enrollment breaks records, and AstraZeneca’s new breast cancer treatment is FDA ...

Dorothy Fink halts reports from health agencies like the CDC, FDA and National Institutes of Health on Tuesday, The H5 bird flu is widespread in wild birds and is causing outbreaks in poultry and ...

The latest funding is a sign of how seriously the Biden administration appears to be taking the pandemic threat.

Moderna has been testing an mRNA candidate for influenza viruses like the H5 and H7 strains that are seen as pandemic threats ...

Vaccine makers' stocks surged on Tuesday after the US reported its first bird flu death. Moderna, Novavax, and CureVac saw double-digit gains, while Pfizer and GSK also rose. The drugmakers have ...

CureVac is developing an mRNA bird flu shot in collaboration with London-based pharma giant GlaxoSmithKline (GLAXO.BO). Pfizer stock (PFE) ticked up a much more modest 0.9%, while GSK itself ...